Key Points - The annual general meeting of the company will be held on June 10, 2025, with no proposals for addition, rejection, or changes [1] - A total of 270 shareholders and proxies attended the meeting, representing 333,060,816 shares, accounting for 59.84% of the total voting shares [1] - The meeting passed several proposals, including ordinary resolutions for proposals 1, 2, 3, 4, 5, 7, 8, 13, and 14, and special resolutions for proposals 12 and 15 [2][3] - The voting results showed a high approval rate, with over 99% of votes in favor for most proposals, indicating strong shareholder support [2][3][5] - The company appointed two non-independent directors, Mr. Zhang Wei and Mr. Jia Hongbin, to the board, ensuring that the number of management and employee representatives does not exceed half of the total board members [6]
国药一致: 2024年年度股东大会决议公告